BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/15/2020 11:56:29 AM | Browse: 609 | Download: 1888
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 52589
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Tian-Yu Xie, Di Wu, Shuo Li, Zhao-Yan Qiu, Qi-Ying Song, Da Guan, Li-Peng Wang, Xiong-Guang Li, Feng Duan and Xin-Xin Wang
Funding Agency and Grant Number
Corresponding Author Xin-Xin Wang, MD, Assistant Professor, Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. 301wxx@sina.com
Key Words Hyperthermic intraperitoneal chemotherapy; Gastric cancer; Prognosis; Locally advanced; Overall survival; Disease-free survival
Core Tip This was a prospective analysis performed with patients with cT4N0-3M0 gastric cancer to compare the effects of postoperative prophylactic hyperthermic intraperitoneal chemotherapy plus intravenous chemotherapy with those of routine adjuvant chemotherapy. Prophylactic hyperthermic intraperitoneal chemotherapy after radical tumor surgery is beneficial to reduce peritoneal tumor recurrence and prolong survival.
Publish Date 2020-07-15 11:47
Citation Xie TY, Wu D, Li S, Qiu ZY, Song QY, Guan D, Wang LP, Li XG, Duan F, Wang XX. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World J Gastrointest Oncol 2020; 12(7): 782-790
URL https://www.wjgnet.com/1948-5204/full/v12/i7/782.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i7.782
Full Article (PDF) WJGO-12-782.pdf
Full Article (Word) WJGO-12-782.docx